Pura Vida Investments — 2022 Investments
3 investments dated 2022 · listed companies and verified rows first · show all
Sonendo is a medical technology company that develops and manufactures the GentleWave System, a technology platform for treating tooth decay by cleaning and disinfecting the interior spaces of teeth without removing tooth structure.
HardwareHealthtechMedical DevicesLaguna Hills, US
Bjarne Bergheim(Executive Officer, Director)inJohn McGaugh(Executive Officer)inJohn Bostjancic(Executive Officer)Hugh Neuharth(Executive Officer)Roy T. Chen(Chief Talent Officer)Chris Guo(Interim Chief Financial Officer)
Co-investorsEssex Woodlands Healthcare PartnersFjord VenturesGeneral AtlanticMeritech Capital PartnersOrbiMedWelsh, Carson, Anderson & Stowe
Cleerly develops FDA-cleared, AI-driven analysis of noninvasive coronary CT (CCTA) imaging to characterize and quantify coronary artery disease.
AI & Machine LearningDigital HealthHealthtechMedical DevicesDenver, US
James Min, MD(Founder)inJames K. Min(Executive Officer, Director)in
BoardLee Cooper(Director)Peter Justin Klein(Director)Scott Barclay(Director)inLouis Samson(Director)
Co-investorsBattery VenturesBreyer CapitalDigiTx Partners LLCInsight PartnersLRVHealthNew Leaf Venture Partners+3 more
Metagenomi Therapeutics is an in vivo genome editing company that uses genetic material sourced from natural environments (metagenomics) to develop a toolbox of editing tools for deletion, integration, and correction of genetic mutations.
BiotechDeep TechMedical DevicesBerkeley, US
Brian Thomas(Executive Officer, Director, Promoter)in
BoardAndrew Farquharson(Director)Jak Knowles(Director)
Co-investorsCatalio Capital Management, LPRA CapitalSozo VenturesAgent CapitalFrazier Life SciencesHumboldt+5 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.